Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan
Mustafa et al.,
Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters..,
Exploratory Research in Clinical and Social Pharmacy, doi:10.1016/j.rcsop.2021.100101
Retrospective 444 hospitalized patients in Pakistan, showing lower mortality with remdesivir treatment in unadjusted results, not reaching statistical significance.
[Gérard, Zhou] show significantly increased risk of acute kidney injury with remdesivir.
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
risk of death, 32.7% lower, RR 0.67, p = 0.21, treatment 16 of 200 (8.0%), control 29 of 244 (11.9%), NNT 26.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Mustafa et al., 29 Dec 2021, retrospective, Pakistan, peer-reviewed, 7 authors.
Abstract: Journal Pre-proof
Pattern of medication utilization in hospitalized patients with
COVID-19 in three District Headquarters Hospitals in the Punjab
province of Pakistan
Zia Ul Mustafa, Chia Siang Kow, Muhammad Salman, Mahpara
Kanwal, Muhammad Bilal Riaz, Samina Parveen, Syed Shahzad
Hasan
PII:
S2667-2766(21)00101-3
DOI:
https://doi.org/10.1016/j.rcsop.2021.100101
Reference:
RCSOP 100101
To appear in:
Received date:
29 September 2021
Revised date:
15 December 2021
Accepted date:
27 December 2021
Please cite this article as: Z.U. Mustafa, C.S. Kow, M. Salman, et al., Pattern of medication
utilization in hospitalized patients with COVID-19 in three District Headquarters
Hospitals in the Punjab province of Pakistan, (2021), https://doi.org/10.1016/
j.rcsop.2021.100101
This is a PDF file of an article that has undergone enhancements after acceptance, such
as the addition of a cover page and metadata, and formatting for readability, but it is
not yet the definitive version of record. This version will undergo additional copyediting,
typesetting and review before it is published in its final form, but we are providing this
version to give early visibility of the article. Please note that, during the production
process, errors may be discovered which could affect the content, and all legal disclaimers
that apply to the journal pertain.
© 2021 Published by Elsevier Inc.
Journal Pre-proof
Pattern of medication utilization in hospitalized patients with COVID-19 in three
District Headquarters Hospitals in the Punjab province of Pakistan
Zia Ul Mustafa1, Chia Siang Kow2,3, Muhammad Salman4, Mahpara Kanwal5, Muhammad Bilal Riaz6,
Samina Parveen6, Syed Shahzad Hasan7,8
1
Department of Pharmacy Services, District Headquarter (DHQ) Hospital, Pakpattan 57400, Pakistan,
Zia.ucp@gmail.com
2
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
3
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia
4
Department
of
Pharmacy,
The
University
of
the
Department
of
Pharmacy
Services,
District
(DHQ)
Hospital,
Chakwal,
Pr
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield,
United Kingdom
School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia
Jo
u
rn
al
8
Headquarter
e-
drbilalriaz@gmail.com & Rphsaminak@gmail.com
7
Pakistan,
oo
mahparakanwal89@gmail.com
6
54000
Department of Pharmacy Services, District Headquarter (DHQ) Hospital, Okara South City, Pakistan,
pr
5
Lahore
f
msk5012@gmail.com
Lahore,
Abstract
Journal Pre-proof
Purpose
In Pakistan, a wide range of repurposed drugs are recommended to manage hospitalized patients
with COVID-19. Therefore, the current study was conducted to evaluate the pattern of utilization of
repurposed drugs and other potential therapeutic options among hospitalized patients with COVID19 in Pakistan.
Methods
This retrospective, multicenter, descriptive study enrolled consecutive hospitalized patients with
COVID-19 who were admitted between March 1, 2021, and April 30, 2021, from three District
Headquarter Hospitals in the Punjab province of Pakistan. We describe patient and clinical
characteristics and medications, stratified by COVID-19 severity during hospitalization: mild,
moderate, and severe. In addition, an analytical study of drug utilization was conducted.
oo
f
Findings
Pr
e-
pr
A total of 444 hospitalized patients with..
Late treatment
is less effective
mustafa
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit